금융 뉴스 허브
실시간 글로벌 금융 시장 뉴스 · 분석 · 인사이트
BREAKING주요 뉴스
Global Oil Security Looks Shakier as Conflicts Hit 45 Million Bpd of Supply
Almost half of the world’s oil supply is produced in regions currently engaged in hot conflicts, Reu...
Gold retreats from three-month high to near $4,600 after US PCE data
Gold price (XAU/USD) falls to near $4,610 during the early Asian session on Thursday. The precious m...
3 Reasons Investors Love American Superconductor (AMSC)
While the S&P 500 is up 11.4% since January 2026, American Superconductor (currently trading at $32.76 per share) has lagged behind, posting a return of 5.1%. This may have investors wondering how to ...
Utility stocks support FTSE 100 in nervy trade
The FTSE 100 Index closed up 28.13 points at 10,600.37.
Bloom Energy (BE): 3 Reasons We Love This Stock
Bloom Energy currently trades at $205.07 and has been a dream stock for shareholders. It’s returned 912% since July 2021, blowing past the S&P 500’s 77.6% gain. The company has also beaten the index o ...
3 Reasons to Sell MTH and 1 Stock to Buy Instead
Meritage Homes has been treading water for the past six months, recording a small return of 3.8% while holding steady at $77.46. The stock also fell short of the S&P 500’s 11.4% gain during that perio ...
NetApp sees largely positive views at Susquehanna heading into H2
3 Big Reasons to Love Nicolet Bankshares (NIC)
Since July 2021, the S&P 500 has delivered a total return of 77.6%. But one standout stock has nearly doubled the market - over the past five years, Nicolet Bankshares has surged 150% to $171.90 per s ...
Palo Alto leads security stocks up, while most enterprise software names inch down
3 Reasons HIMS Has Explosive Upside Potential
Hims & Hers Health trades at $33.39 per share and has stayed right on track with the overall market, gaining 9.6% over the last six months. At the same time, the S&P 500 has returned 11.4%.
Simmons First National signals deposit investments as it targets 9%-11% 2026 net interest income growth
2 Reasons to Avoid BMRN and 1 Stock to Buy Instead
BioMarin Pharmaceutical trades at $59.99 per share and has stayed right on track with the overall market, gaining 6.5% over the last six months. At the same time, the S&P 500 has returned 11.4%.
Apple’s ‘Wait and See’ AI Strategy Just Earned the Stock an Upgrade
The company is letting its Big Tech peers pony up for research and development and then is ready to swoop in to grab the best models when the dust settles.
CarMax (KMX) Up 9% Since Last Earnings Report: Can It Continue?
CarMax (KMX) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.